Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers-Reference-Cited by-同舟云学术

Effects of atomoxetine on the QT interval in healthy CYP2D6 poor metabolizers

Published:2013-01-10 Issue:2 Volume:75 Page:549-564
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Loghin Corina¹,Haber Harry²,Beasley Charles M.¹,Kothare Prajakti A.,Kauffman Lynnette,April John¹,Jin Ling¹,Allen Albert J.¹,Mitchell Malcolm I.¹

Affiliation:

1. Eli Lilly and Company; Indianapolis; IN; 46285; USA

2. Department of Statistics; Pharmanet/i3, Inc.; Ann Arbor; MI; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2012.04382.x/fullpdf

Reference30 articles.

1. ICH Guidance for industry E14 clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs http://www.fda.gov/downloads/RegulatoryInformation/Guidances/ucm129357.pdf

2. Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents;Scherer;Br J Pharmacol,2009

3. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: cisapride versus dofetilide;Milnes;J Pharmacol Toxicol Methods,2010

4. Clinical pharmacokinetics of atomoxetine;Sauer;Clin Pharmacokinet,2005

5. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder;Simpson;Drugs,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence;European Journal of Clinical Pharmacology;2023-01-16

2. The use of attention-deficit hyperactivity disorder medications in cardiac disease;Frontiers in Neuroscience;2022-10-19

3. Methylphenidate-Associated Syncope;Journal of Clinical Psychopharmacology;2022-06-11

4. Management of Orthostatic Hypotension in the Hospitalized Patient: A Narrative Review;The American Journal of Medicine;2022-01

5. Cardiovascular Effects of Drugs Used to Treat Attention-Deficit/Hyperactivity Disorder;Cardiology in Review;2019-05